Innovative Cell Therapies Catamaran Bio specializes in off-the-shelf CAR-NK cell therapies targeting solid tumors, representing a promising solution for healthcare providers seeking advanced cancer treatments with scalable and immediate availability.
Growing R&D Platform With the launch of its proprietary TAILWIND platform designed to enhance NK cell engineering and processing, Catamaran offers opportunities for collaboration on next-generation cell therapy development and customization.
Strategic Partnerships Existing collaborations with MaxCyte and OmniaBio highlight opportunities for supply chain integration and manufacturing partnerships to accelerate therapy development and commercialization.
Funding & Market Potential With a funding level of 42 million dollars and revenues between 1 to 10 million dollars, Catamaran is positioned as a growth-stage company with potential for expansion into larger biotech markets and partnerships.
Market Focus on Oncology Targeting the expanding oncology segment with innovative cell therapies, Catamaran presents opportunities to connect with hospitals, research institutes, and biotech firms focusing on cancer treatment advancements.
$50M$100M
$10M$25M
$1M
$1M$10M
$25M$50M
$1M$10M
$10M$25MCatamaran Bio uses 8 technology products and services including Shopify, jQuery Migrate, jQuery, and more. Explore Catamaran Bio's tech stack below.
| Catamaran Bio Email Formats | Percentage |
| FLast@catamaranbio.com | 40% |
| First@catamaranbio.com | 10% |
| FLast@catamaranbio.com | 40% |
| First@catamaranbio.com | 10% |
Biotechnology ResearchMassachusetts, United States11-50 Employees
At Catamaran, our mission is to harness the power of our proprietary TAILWIND™ Platform to develop safe and effective, off-the-shelf, allogeneic immune cell therapies for the treatment of patients with cancer and immune disorders.
Company Overview
Media & News
Funding & FinancialsCatamaran Bio has raised a total of $42M of funding over 1 rounds. Their latest funding round was raised on Nov 23, 2020 in the amount of $42M.
Catamaran Bio's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsCatamaran Bio has raised a total of $42M of funding over 1 rounds. Their latest funding round was raised on Nov 23, 2020 in the amount of $42M.
Catamaran Bio's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com